Mangmang Sang
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 3
- Biochemistry top 10%
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds 2
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 11
-
- Advanced biosensing and bioanalysis techniques 3
-
- Natural Compound Pharmacology Studies 2
-
- Ferroptosis and cancer prognosis 2
-
- Advanced Nanomaterials in Catalysis 2
- Luminescence and Fluorescent Materials 2
- Journals
- ACS Nano (1 paper)Advanced Functional Materials (1 paper)ACS Applied Materials & Interfaces (2 papers)
- Partner nations
- ChinaNetherlandsUnited States
In The Last Decade
Mangmang Sang
21 papers receiving 792 citations
Peers
Comparison fields: 5 of 84
- Biomaterials 119
- Biochemistry 61
- Cancer Research 119
- Pharmacology 68
- Biomedical Engineering 332
Countries citing papers authored by Mangmang Sang
This map shows the geographic impact of Mangmang Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mangmang Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mangmang Sang more than expected).
Fields of papers citing papers by Mangmang Sang
This network shows the impact of papers produced by Mangmang Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mangmang Sang. The network helps show where Mangmang Sang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mangmang Sang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 10 | |
| 3 | 2023 | 46 | |
| 4 | 2023 | 51 | |
| 5 | 2022 | 93 | |
| 6 | 2021 | 24 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 26 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 24 | |
| 11 | 2019 | 42 | |
| 12 | 2019 | 133 | |
| 13 | 2019 | 30 | |
| 14 | 2019 | 59 | |
| 15 | 2018 | 77 | |
| 16 | 2018 | 11 | |
| 17 | 2018 | 19 | |
| 18 | 2017 | 30 | |
| 19 | 2017 | 70 | |
| 20 | 2015 | 21 |
About Mangmang Sang
Mangmang Sang is a scholar working on Toxicology, Biomedical Engineering and Biomaterials, having authored 22 papers that have together received 795 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Natural Compound Pharmacology Studies (2 papers), Ferroptosis and cancer prognosis (2 papers), Advanced Nanomaterials in Catalysis (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Luminescence and Fluorescent Materials (2 papers). The work is most often cited by research in Biomaterials (119 citations), Biochemistry (61 citations) and Cancer Research (119 citations). Mangmang Sang has collaborated with scholars based in China, Netherlands and United States. Frequent co-authors include Wenyuan Liu, Jinrong Zheng, Renjie Luo, Gang� Li, Fulei Liu, Cuilian Dai, Feng Feng, Jun Dou, Erwei Liu and Lifeng Han. Their work appears in journals such as ACS Nano, Advanced Functional Materials and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.